| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 08/20/2002 | US6436989 Prodrugs of aspartyl protease inhibitors |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436960 Farnesyl transferase inhibitors having a piperidine structure and process for preparation thereof |
| 08/20/2002 | US6436955 Storage stable, less hygroscopic, bactericide |
| 08/20/2002 | US6436951 Camptothecin tetracyclic analogues, preparation, method, applications as medicines and pharmaceutical compositions containing them |
| 08/20/2002 | US6436932 Psychiatric disorders and neurological diseases; corticotropin releasing factor; pyrrolo(2,3-d)pyrimidine derivatives |
| 08/20/2002 | US6436930 Thio derivatives of sordarin as antifungal agents |
| 08/20/2002 | US6436921 Have low minimum inhibitory concentrations for grampositive and gramnegative strains, are stable against degradation by renal dehydropeptidase-i and have excellent bioavailability |
| 08/20/2002 | US6436906 Novel macrolides having antibacterial activity toward grampositive and gramnegative bacteria as well as macrolide resistant grampositives |
| 08/20/2002 | US6436702 Vaccines and antibodies to treat nervous necrosis virus in fish |
| 08/20/2002 | US6436634 Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes |
| 08/20/2002 | US6436444 Acidic aqueous chlorite teat dip providing shelf life sanitizing capacity and tissue protection |
| 08/20/2002 | US6436410 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 08/20/2002 | US6436408 Cold -adapted equine influenza viruses |
| 08/20/2002 | US6436402 Process for making human papillomavirus virus-like particles with improved properties |
| 08/20/2002 | US6436390 IL8 inhibitors |
| 08/20/2002 | US6436344 Method of inactivating pathogens |
| 08/20/2002 | US6435873 Medication delivery devices |
| 08/20/2002 | CA2255663C Antifungal composition with enhanced bioavailability |
| 08/20/2002 | CA2225530C A method for the control of antibiotic-resistant gram positive bacteria and treatment of infection |
| 08/20/2002 | CA2216129C Lactam-containing hydroxamic acids |
| 08/20/2002 | CA2210353C Stabilized external guide sequences |
| 08/20/2002 | CA2145664C Oligonucleotides having a conserved g4 core sequence |
| 08/20/2002 | CA2111340C Novel polypeptides and their use |
| 08/20/2002 | CA2098404C Improved humanized immunoglobulins |
| 08/20/2002 | CA2072366C carboxylic acid-metal ion-acid complexes |
| 08/15/2002 | WO2002063008A2 Intracellular signaling molecules |
| 08/15/2002 | WO2002063006A2 Receptors and membrane-associated proteins |
| 08/15/2002 | WO2002063004A2 G-protein coupled receptors |
| 08/15/2002 | WO2002062999A2 Proteins and nucleic acids encoding same |
| 08/15/2002 | WO2002062959A2 Hepatitis b virus treatment |
| 08/15/2002 | WO2002062840A1 INTERFERON-α INDUCED GENE |
| 08/15/2002 | WO2002062834A2 Mixture of peptides originating from a nef protein and applications thereof |
| 08/15/2002 | WO2002062831A1 Novel peptides, derivatives thereof, process for producing the same, novel strains producing the same and antiviral agents containing the same as the active ingedient |
| 08/15/2002 | WO2002062830A1 Tripeptide derivatives for the treatment of neurodegenerative diseases |
| 08/15/2002 | WO2002062813A1 Novel substance having physiological activity, process for producing the same, and use |
| 08/15/2002 | WO2002062810A2 Linkable sialyl lewis x analogs |
| 08/15/2002 | WO2002062804A1 Oxazolyl-pyrazole derivatives as kinase inhibitors |
| 08/15/2002 | WO2002062800A1 Bicyclic nitrogenous fused-ring compound |
| 08/15/2002 | WO2002062793A1 Thiazole compounds as tgf-beta inhibitors |
| 08/15/2002 | WO2002062789A1 Pyrazole compounds useful as protein kinase inhibitors |
| 08/15/2002 | WO2002062788A1 Sulfonamide compounds, their preparation and use |
| 08/15/2002 | WO2002062787A1 Pyrazoles as tgf inhibitors |
| 08/15/2002 | WO2002062777A2 Amino ceramide-like compounds and therapeutic methods of use |
| 08/15/2002 | WO2002062776A1 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors |
| 08/15/2002 | WO2002062767A1 Novel quinazoline derivatives |
| 08/15/2002 | WO2002062750A1 Cannabinoid receptor ligands |
| 08/15/2002 | WO2002062423A1 Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| 08/15/2002 | WO2002062403A1 A medical dressing comprising an antimicrobial silver compound |
| 08/15/2002 | WO2002062392A2 Water-soluble compositions of bioactive lipophilic compounds |
| 08/15/2002 | WO2002062380A2 Chlamydia vaccine composition |
| 08/15/2002 | WO2002062378A2 Hyperblebbing bacterial strains and use thereof for production of vaccines |
| 08/15/2002 | WO2002062368A2 Method of inducing a ctl response |
| 08/15/2002 | WO2002062364A1 Antiviral composition made from medicinal plants for combating hiv/aids |
| 08/15/2002 | WO2002062362A2 Antiviral and antibacterial composition |
| 08/15/2002 | WO2002062361A1 Antiviral composition containing propolis and essential oils |
| 08/15/2002 | WO2002062360A1 Endotoxin binding by lactic acid bacteria and bifidobacteria |
| 08/15/2002 | WO2002062339A1 Antibacterial compounds |
| 08/15/2002 | WO2002062337A1 Thiazolidinediones |
| 08/15/2002 | WO2002062336A1 Antifungal remedy formulation for external application |
| 08/15/2002 | WO2002062335A2 Implantable device containing resorbable matrix material and anti-proliferative drugs for preventing or treating failure of hemodialysis vascular access and other vascular grafts |
| 08/15/2002 | WO2002062333A1 Use of 9h-xanthenes in a method of inhibiting viral replication targeting the nucleocapsid protein |
| 08/15/2002 | WO2002062331A1 Cyanoacrylate compositions for prophylactic or therapeutic treatment of diseases manifesting themselves in and/or damaging cutaneous tissue |
| 08/15/2002 | WO2002062318A2 Oral itraconazole formulations and methods of making the same |
| 08/15/2002 | WO2002062298A2 Pro-apoptotic bacterial vaccines to enhance cellular immune responses |
| 08/15/2002 | WO2002062293A2 Coumarin compounds as microtubule stabilizing agents and therapeutic uses thereof |
| 08/15/2002 | WO2002062290A2 Heterocyclic substituted 2-methyl-benzimidazole antiviral agents |
| 08/15/2002 | WO2002050101A8 Retinoblastoma-binding protein |
| 08/15/2002 | WO2002042429A3 Methods of isolating amyloid-inhibiting compounds and use of compounds isolated from uncaria tomentosa and related plants |
| 08/15/2002 | WO2002042266A3 Process for the production of ceftifur sodium salt |
| 08/15/2002 | WO2002034753A3 Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 08/15/2002 | WO2002032915B1 Combinatorial libraries of monosaccharides |
| 08/15/2002 | WO2002030860A3 Ketone compounds and compositions for cholesterol management and related uses |
| 08/15/2002 | WO2002028866A3 Hydroxyesters of 7-desmethylrapamycin |
| 08/15/2002 | WO2002028434A3 Use of a ppar delta activator for treating inflammatory conditions |
| 08/15/2002 | WO2002028433A3 Use of a ppar delta activator in the treatment of diseases related to no inhibit ion or tnf inhibition |
| 08/15/2002 | WO2002026249A3 Methods for inhibition of viral infection |
| 08/15/2002 | WO2002022160A3 The diagnosis, prevention, amelioration and/or treatment of disturbed immune function induced by disturbed lipid metabolism |
| 08/15/2002 | WO2002018369A3 Peptidomimetic protease inhibitors |
| 08/15/2002 | WO2002016381B1 Composition and method for inhibiting platelet aggregation |
| 08/15/2002 | WO2002013763A3 Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists |
| 08/15/2002 | WO2002011724A3 Neuroprotective 2-pyridinamine compositions and related methods |
| 08/15/2002 | WO2002008446A3 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
| 08/15/2002 | WO2002006303A3 Dna vaccines encoding hiv accessory proteins |
| 08/15/2002 | WO2002000263A3 Tripeptide prodrug compounds |
| 08/15/2002 | WO2001095945A3 Prodrug compounds cleavable by thimet oligopeptidase |
| 08/15/2002 | WO2001079246A3 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of hepatitis virus infections |
| 08/15/2002 | WO2001066572A9 Polynucleotides isolated from e. coli of nature b2/d+ a-, and uses thereof |
| 08/15/2002 | WO2001057079A3 C1 inhibitor produced in the milk of transgenic mammals |
| 08/15/2002 | WO2001034801A9 Recombinant gelatin in vaccines |
| 08/15/2002 | WO2001034168A9 Inhibition of pathogens by bacillus coagulans strains |
| 08/15/2002 | WO2001032877A9 CpG RECEPTOR (CpG-R) AND METHODS RELATING THERETO |
| 08/15/2002 | WO2001016182A3 POLYPEPTIDES THAT BIND HIV gp120 AND RELATED NUCLEIC ACIDS, ANTIBODIES, COMPOSITIONS, AND METHODS OF USE |
| 08/15/2002 | WO1999064067A9 Vaccine |
| 08/15/2002 | US20020111493 Amidino compounds useful as nitric oxide synthase inhibitors |
| 08/15/2002 | US20020111378 Inhibitors of IMPDH enzyme |
| 08/15/2002 | US20020111370 Compounds useful as antibacterial agents |
| 08/15/2002 | US20020111368 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 08/15/2002 | US20020111353 Antiinflammatory agents; central nervous system disorders;antidiabgetic agents; rheumatic disorders |
| 08/15/2002 | US20020111349 Method for treatment and prevention of mastitis |